secwatch.observer — SEC 8-K summary
======================================

Issuer:     CalciMedica, Inc. (CALC)
CIK:        0001534133
Form:       8-K
Filed at:   2025-01-14T23:59:59+00:00
Accession:  0001193125-25-005654
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CalciMedica director Eric Bjerkholt resigns; Alan Glicklich appointed to board
------------------------------------------------------------------------------

- Eric Bjerkholt resigned as director and audit committee chair effective Jan 15, 2025; no disagreement with company.
- Board appointed Alan Glicklich, M.D. as Class I director effective same date, term expires at 2027 annual meeting.
- Dr. Glicklich receives $40,000 annual cash retainer (pro-rated) and option for 20,000 shares vesting over three years.
- No arrangements or transactions requiring disclosure under Item 404(a) between Dr. Glicklich and company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534133/000119312525005654/0001193125-25-005654-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534133/000119312525005654/d902412d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-005654

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer